GREENWICH, Conn. - TelAve -- Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet

Experienced, Recognized Orthopedic Business and Surgical Professionals to Help Identify and  Evaluate Strategic Opportunities

Old Greenwich, CT – May 1, 2025 - Mission 3A, a venture studio focused on transforming and scaling breakthrough companies, announced today that its healthcare division, Mission 3A Healthcare, has established a Healthcare Advisory Board and appointed industry leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet.

"We are honored to welcome Patrick, Kevin, and Dr. Berlet to our advisory board. Their collective experience spanning investment, commercialization, and clinical leadership will provide invaluable guidance as we build  and back the next generation of healthcare innovation," said Andy Reid, Partner and COO of Mission 3A's  Healthcare Portfolio. "These appointments bring a powerful combination of clinical insight, commercial  acumen, and strategic guidance to Mission 3A, as we expand our efforts to accelerate high-impact startups at  the intersection of healthcare, AI, and digital health."

More on TelAve News

• SSATI Completes Acquisition of Invex Technology Solutions and ITIC Corporation's Government Support Services
• New Podcast "Change Cycle" Unpacks the Complexity of Driving Systemic Change Toward a Circular Economy
• Rkaydz Video Game Museum Launches "Acquisition Series"
• Coastguard Nelson (NZ) selects Omnitronics omnicore Express Dispatch - Completing their transition from analog to digital
• First Choice Neurology Partners with NeuroDiscovery AI to Advance Neurological Care and Research

"Joining the Mission 3A Healthcare Advisory Board is an exciting opportunity to help shape the future of  MedTech and AI innovation," said Dr. Greg Berlet. "I'm thrilled to contribute my clinical and entrepreneurial  experience to a team that's already making a measurable impact in healthcare."

• Patrick Fisher, President of Global Orthopedics at Orthofix and former executive at Stryker and Wright  Medical, is a commercial leader with deep expertise in orthopedics, biologics, and global strategy.
• Kevin Cordell, has overseen multi-billion dollar orthopedic and cardiovascular businesses, launched  market-leading innovations, and helped deliver significant shareholder value—including the $5.4B  acquisition of Wright Medical by Stryker.
• Greg Berlet, MD, a globally recognized orthopedic surgeon, innovator and educator with extensive experience in clinical leadership and medical education.  Dr. Berlet has authored over 150 peer-reviewed scientific articles and has been instrumental in the design and development of numerous orthopedic implants.

About Mission 3A

More on TelAve News

• Is Billboard Advertising Still Effective in 2025?
• Climate Masters Inc. Poised for Record-Breaking Year in 2025
• Indie Game Publisher Joins Federal Lawsuit Challenging Trump Administration's Illegal Tariffs
• Care Dental Implant & Cosmetic Center's New Website Launch!
• $4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP

Mission 3A is a venture studio dedicated to launching and scaling breakthrough companies. The Mission 3A  Healthcare Portfolio focuses on building and investing in MedTech and Healthcare AI startups that improve  access, affordability, patient outcomes, and operational efficiency. Backed by experienced operators and  investors, the firm partners closely with founders to drive transformative impact through AI, SaaS, and  platform-based solutions.
www.mission3a.com